David M. Jackson

5.1k total citations
89 papers, 2.8k citations indexed

About

David M. Jackson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, David M. Jackson has authored 89 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cellular and Molecular Neuroscience, 28 papers in Molecular Biology and 25 papers in Pharmacology. Recurrent topics in David M. Jackson's work include Neurotransmitter Receptor Influence on Behavior (48 papers), Neuroscience and Neuropharmacology Research (26 papers) and Cannabis and Cannabinoid Research (21 papers). David M. Jackson is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (48 papers), Neuroscience and Neuropharmacology Research (26 papers) and Cannabis and Cannabinoid Research (21 papers). David M. Jackson collaborates with scholars based in Australia, Sweden and United States. David M. Jackson's co-authors include G. B. Chesher, Nils-Erik And�n, Annica Dahlstr�m, Christina Johansson, Lennart Svensson, G A Starmer, Owen Jenkins, Jianhua Zhang, Dale M. Atrens and C. Johansson and has published in prestigious journals such as Brain Research, The FASEB Journal and The Journal of Urology.

In The Last Decade

David M. Jackson

88 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Jackson Australia	31	1.8k	914	612	366	302	89	2.8k
Maria Collu Italy	27	1.8k 1.0×	1.0k 1.1×	459 0.8×	421 1.2×	393 1.3×	79	3.2k
Wiel Honig Netherlands	25	1.4k 0.8×	653 0.7×	373 0.6×	347 0.9×	606 2.0×	47	2.7k
E. S. Vizi Hungary	21	1.6k 0.8×	1.3k 1.4×	325 0.5×	237 0.6×	445 1.5×	50	2.7k
Montford F. Piercey United States	34	2.0k 1.1×	1.2k 1.3×	301 0.5×	412 1.1×	711 2.4×	82	3.3k
R. S. Duman United States	8	2.5k 1.4×	922 1.0×	627 1.0×	515 1.4×	283 0.9×	9	3.8k
R. Steinberg France	27	1.9k 1.0×	1.6k 1.8×	473 0.8×	175 0.5×	384 1.3×	59	2.8k
Tiziana Antonelli Italy	38	2.2k 1.2×	1.2k 1.3×	921 1.5×	718 2.0×	288 1.0×	108	3.8k
Anne‐Marie Laporte France	24	2.1k 1.2×	1.3k 1.4×	312 0.5×	321 0.9×	434 1.4×	34	2.7k
Jean‐Marie Vaugeois France	29	2.0k 1.1×	1.6k 1.7×	579 0.9×	340 0.9×	410 1.4×	61	4.4k
Emilio Fernández‐Espejo Spain	27	1.3k 0.7×	533 0.6×	607 1.0×	369 1.0×	387 1.3×	89	2.4k

Countries citing papers authored by David M. Jackson

Since Specialization

Citations

This map shows the geographic impact of David M. Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Jackson more than expected).

Fields of papers citing papers by David M. Jackson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Jackson. The network helps show where David M. Jackson may publish in the future.

Co-authorship network of co-authors of David M. Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Jackson. A scholar is included among the top collaborators of David M. Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Jackson. David M. Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vincenzi, Bruno, Ajay Duggal, Pamela Guglielmini, et al.. (2020). Neurokinin-1 antagonist orvepitant for EGFRI-induced pruritus in patients with cancer: a randomised, placebo-controlled phase II trial. BMJ Open. 10(2). e030114–e030114. 11 indexed citations

Ghergherehchi, Cameron L., Michelle Mikesh, Dale R. Sengelaub, et al.. (2018). Polyethylene glycol (PEG) and other bioactive solutions with neurorrhaphy for rapid and dramatic repair of peripheral nerve lesions by PEG-fusion. Journal of Neuroscience Methods. 314. 1–12. 39 indexed citations

Nevin, Christa R., Inmaculada Aban, Michael J. Mugavero, et al.. (2011). The Role of Toxicity-Related Regimen Changes in the Development of Antiretroviral Resistance. AIDS Research and Human Retroviruses. 27(9). 957–963. 4 indexed citations

Peeling, James, et al.. (2001). Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke. Neuropharmacology. 40(3). 433–439. 101 indexed citations

Martin, Lynn P., et al.. (1999). Electrophysiological Comparison of 5-Hydroxytryptamine1A Receptor Antagonists on Dorsal Raphe Cell Firing. Journal of Pharmacology and Experimental Therapeutics. 288(2). 820–826. 45 indexed citations

Homan, Evert, et al.. (1999). Synthesis and pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT. Bioorganic & Medicinal Chemistry. 7(7). 1263–1271. 5 indexed citations

Jackson, David M., et al.. (1998). A pharmacological validation of radiotelemetry in conscious, freely moving rats. Journal of Pharmacological and Toxicological Methods. 40(2). 71–79. 25 indexed citations

Zhang, Jianhua, Jörgen A. Engel, David M. Jackson, Christina Johansson, & Lennart Svensson. (1997). (−)Alprenolol potentiates the disrupting effects of dizocilpine on sensorimotor function in the rat. Psychopharmacology. 132(3). 281–288. 13 indexed citations

Jackson, David M., Nina Mohell, Å. Bengtsson, & Åsa Malmberg. (1995). Why does clozapine stimulate the motor activity of reserpine-pretreated rats when combined with a dopamine D1 receptor agonist?. European Journal of Pharmacology. 282(1-3). 137–144. 5 indexed citations

10.

McGregor, Iain S., et al.. (1994). Constrasting effects of dopaminergic blockade on MDMA and d-amphetamine conditioned taste aversions. Pharmacology Biochemistry and Behavior. 47(2). 369–374. 17 indexed citations

11.

Jackson, David M., et al.. (1994). Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats. Pharmacology Biochemistry and Behavior. 48(2). 465–471. 86 indexed citations

12.

Mohell, Nina, et al.. (1993). Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors. European Journal of Pharmacology. 238(1). 121–125. 43 indexed citations

13.

Christie, MacDonald J., et al.. (1993). Comparison of conditioned taste aversions produced by MDMA and d-amphetamine. Pharmacology Biochemistry and Behavior. 46(1). 153–156. 13 indexed citations

14.

McGregor, Iain S., Dale M. Atrens, & David M. Jackson. (1992). Cocaine facilitation of prefrontal cortex self-stimulation: a microstructural and pharmacological analysis. Psychopharmacology. 106(2). 239–247. 23 indexed citations

15.

Jackson, David M., et al.. (1992). Preferential Stimulation of Locomotor Activity by Ventral Tegmental Microinjections of (—)‐Nicotine. Pharmacology & Toxicology. 70(1). 50–52. 32 indexed citations

16.

Jackson, David M., Svante B. Ross, & Stephen R. Edwards. (1989). Dopamine D2 agonist-induced behavioural depression is reversed by dopamine D1 agonists. Journal of Neural Transmission. 75(3). 213–220. 18 indexed citations

17.

Jackson, David M., et al.. (1989). Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Research. 487(2). 267–277. 157 indexed citations

18.

Ross, Svante B., David M. Jackson, & Stephen R. Edwards. (1989). The Involvement of Dopamine D₁and D₂Receptors in the Locomotor Stimulation Produced by (+)‐Amphetamine in Naive and Dopamine‐Depleted Mice. Pharmacology & Toxicology. 64(1). 72–77. 18 indexed citations

19.

Jackson, David M., Svante B. Ross, & Lars‐Gunnar Larsson. (1989). Dopamine D-2 receptor agonist-induced behavioural depression: critical dependence upon postsynaptic dopamine D-1 function. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(4). 355–365. 28 indexed citations

20.

Beart, Philip M., et al.. (1989). The effects of central dopamine function of chronic L-DOPA (methyl ester hydrochloride) treatment of mice. Pharmacology Biochemistry and Behavior. 33(1). 139–146. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact